Di Zazzo Antonio, Zhu Angela Y, Nischal Ken, Fung Simon S M
Ophthalmology Operative Complex Unit, University Campus Bio-Medico, Rome, Italy.
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United States.
Front Ophthalmol (Lausanne). 2024 Feb 15;4:1328953. doi: 10.3389/fopht.2024.1328953. eCollection 2024.
Vernal keratoconjunctivitis (VKC) is a chronic, progressive, allergic ocular surface disorder that can lead to sight-threatening complications. VKC occurs primarily in children and generally resolves about the time of puberty; however, case series and retrospective analyses indicate that approximately 10% of patients with VKC are adults, and that a subset of adult cases develop after puberty. Consequently, two age-related variants of VKC have recently been described: early-onset VKC-which manifests during childhood and persists into adult life-and late-onset disease, which emerges after puberty. Although the signs and symptoms of adult and childhood VKC are similar, adult VKC is a long-lasting disease characterized by severe inflammation and increased risk of conjunctival fibrosis, which may place adult patients at higher risk for sight-threatening complications and adverse impacts on daily life. This review discusses the epidemiology, signs, symptoms, immunopathogenesis of adult VKC variants, and highlights current gaps in research and management of patients with this condition.
春季角结膜炎(VKC)是一种慢性、进行性、过敏性眼表疾病,可导致威胁视力的并发症。VKC主要发生于儿童,通常在青春期左右痊愈;然而,病例系列研究和回顾性分析表明,约10%的VKC患者为成年人,且一部分成年病例在青春期后发病。因此,最近描述了两种与年龄相关的VKC变体:早发性VKC——在儿童期出现并持续至成年期——和迟发性疾病,在青春期后出现。尽管成人和儿童VKC的体征和症状相似,但成人VKC是一种持久的疾病,其特征是严重炎症和结膜纤维化风险增加,这可能使成年患者面临更高的威胁视力并发症风险以及对日常生活产生不利影响。本综述讨论了成人VKC变体的流行病学、体征、症状、免疫发病机制,并强调了目前在该疾病患者研究和管理方面的差距。